Tag Archives: George Zavoico

Analysts Conflicted on These Healthcare Names: Tocagen Inc (NASDAQ: TOCA) and Anixa Biosciences Inc (NASDAQ: ANIX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tocagen Inc (TOCA – Research Report) and Anixa Biosciences Inc (ANIX – Research Report). Tocagen Inc (TOCA) In a report released yesterday, George

B.Riley FBR Thinks Geron Corp’s Stock is Going to Recover

In a report released today, George Zavoico from B.Riley FBR reiterated a Buy rating on Geron Corp (GERN – Research Report), with a price target of $4.50. The company’s shares closed yesterday at $1.15, close to its 52-week low of

B.Riley FBR Thinks Verastem’s Stock is Going to Recover

B.Riley FBR analyst George Zavoico reiterated a Buy rating on Verastem (VSTM – Research Report) on August 2 and set a price target of $9. The company’s shares closed on Friday at $1.40, close to its 52-week low of $1.16.

B.Riley FBR Maintains a Buy Rating on Infinity Pharma (INFI)

In a report released today, George Zavoico from B.Riley FBR maintained a Buy rating on Infinity Pharma (INFI – Research Report), with a price target of $4.50. The company’s shares closed yesterday at $1.57. Zavoico said: “Yesterday (7/30) morning, Infinity

Analysts Offer Insights on Healthcare Companies: Novavax (NASDAQ: NVAX) and Endo International (NASDAQ: ENDP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novavax (NVAX – Research Report) and Endo International (ENDP – Research Report) with bullish sentiments. Novavax (NVAX) In a report released yesterday,

B.Riley FBR Keeps Their Buy Rating on BioLife Solutions (BLFS)

In a report released today, George Zavoico from B.Riley FBR reiterated a Buy rating on BioLife Solutions (BLFS – Research Report), with a price target of $22. The company’s shares opened today at $11.95. Zavoico said: “Last night, after market